Back

Honokiol and alfa-Mangostin inhibit Mayaro virus replication by stimulating the type I interferon pathway

Valdes-Torres, P.; Campos, D.; Bhakta, M.; Galan-Jurado, P. E.; Durant-Archibold, A. A.; Gonzalez Santamaria, J.

2022-08-21 microbiology
10.1101/2022.08.20.504652 bioRxiv
Show abstract

Mayaro virus (MAYV) is an emerging arbovirus with increasing circulation across the Americas. In the present study, we evaluated the potential antiviral activity of the following natural compounds against MAYV and other arboviruses: Sanguinarine, (R)-Shikonin, Fisetin, Honokiol, Tanshinone IIA and -Mangostin. Sanguinarine and Shikonin showed significant cytotoxicity, whereas Fisetin, Honokiol, Tanshinone IIA and -Mangostin were well-tolerated in all the cell lines tested. Honokiol and -Mangostin treatment protected Vero-E6 cells against MAYV-induced damage and resulted in a dose-dependent reduction in viral progeny yields for each of the MAYV strains and human cell lines assessed. Also, Honokiol and -Mangostin disrupted MAYV infection at different stages of the virus life cycle. Moreover, these compounds decreased Una, Chikungunya and Zika viral titers and downmodulated the expression of E1 and nsP1 viral proteins from MAYV, Una and Chikungunya. Finally, in Honokiol- and -Mangostin-treated cells, we observed an upregulation in the expression of type I interferon and specific interferon-stimulated genes, including IFN, IFN{beta}, MxA, ISG15, OAS2, MDA-5, TNF and IL-1{beta}, which may promote an antiviral cellular state. Our results indicate that Honokiol and -Mangostin present potential broad-spectrum activity against different arboviruses through a possible modulation of the interferon pathway.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Virus Research
36 papers in training set
Top 0.1%
12.3%
2
Viruses
318 papers in training set
Top 0.4%
10.1%
3
Scientific Reports
3102 papers in training set
Top 10%
8.4%
4
Virology
56 papers in training set
Top 0.1%
4.3%
5
Journal of General Virology
46 papers in training set
Top 0.1%
4.3%
6
PLOS ONE
4510 papers in training set
Top 34%
4.3%
7
Antiviral Research
49 papers in training set
Top 0.1%
4.3%
8
Journal of Virology
456 papers in training set
Top 1%
4.3%
50% of probability mass above
9
Journal of Medical Virology
137 papers in training set
Top 0.7%
4.1%
10
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 0.6%
3.6%
11
Microbiology Spectrum
435 papers in training set
Top 1%
3.2%
12
Frontiers in Microbiology
375 papers in training set
Top 3%
3.1%
13
Archives of Virology
14 papers in training set
Top 0.3%
1.7%
14
Journal of Virological Methods
36 papers in training set
Top 0.4%
1.7%
15
Virology Journal
25 papers in training set
Top 0.2%
1.3%
16
Heliyon
146 papers in training set
Top 3%
1.3%
17
Gene
41 papers in training set
Top 1%
1.2%
18
Molecules
37 papers in training set
Top 1%
0.9%
19
Pharmaceuticals
33 papers in training set
Top 1%
0.9%
20
Current Microbiology
18 papers in training set
Top 0.4%
0.9%
21
Microorganisms
101 papers in training set
Top 2%
0.9%
22
PLOS Neglected Tropical Diseases
378 papers in training set
Top 4%
0.9%
23
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 5%
0.9%
24
Microbial Pathogenesis
13 papers in training set
Top 0.6%
0.8%
25
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
26
Pathogens
53 papers in training set
Top 2%
0.7%
27
ACS Infectious Diseases
74 papers in training set
Top 1%
0.7%
28
Life
27 papers in training set
Top 0.5%
0.7%
29
Frontiers in Immunology
586 papers in training set
Top 9%
0.6%
30
Journal of Antimicrobial Chemotherapy
43 papers in training set
Top 0.5%
0.6%